Examination of the efficacy of acute L-alanyl-L-glutamine ingestion during hydration stress in endurance exercise by Jay R Hoffman et al.
RESEARCH ARTICLE Open Access
Examination of the efficacy of acute L-alanyl-L-
glutamine ingestion during hydration stress in
endurance exercise
Jay R Hoffman1*, Nicholas A Ratamess1, Jie Kang1, Stephanie L Rashti1, Neil Kelly1, Adam M Gonzalez1,
Michael Stec1, Steven Anderson1, Brooke L Bailey2, Linda M Yamamoto2, Lindsay L Hom2, Brian R Kupchak2,
Avery D Faigenbaum1, Carl M Maresh2
Abstract
Background: The effect of acute L-alanyl-L-glutamine (AG; Sustamine™) ingestion on performance changes and
markers of fluid regulation, immune, inflammatory, oxidative stress, and recovery was examined in response to
exhaustive endurance exercise, during and in the absence of dehydration.
Methods: Ten physically active males (20.8 ± 0.6 y; 176.8 ± 7.2 cm; 77.4 ± 10.5 kg; 12.3 ± 4.6% body fat)
volunteered to participate in this study. During the first visit (T1) subjects reported to the laboratory in a
euhydrated state to provide a baseline (BL) blood draw and perform a maximal exercise test. In the four
subsequent randomly ordered trials, subjects dehydrated to -2.5% of their baseline body mass. For T2, subjects
achieved their goal weight and were not rehydrated. During T3 - T5, subjects reached their goal weight and then
rehydrated to 1.5% of their baseline body mass by drinking either water (T3) or two different doses (T4 and T5) of
the AG supplement (0.05 g·kg-1 and 0.2 g·kg-1, respectively). Subjects then exercised at a workload that elicited 75%
of their VO2 max on a cycle ergometer. During T2 - T5 blood draws occurred once goal body mass was achieved
(DHY), immediately prior to the exercise stress (RHY), and immediately following the exercise protocol (IP). Resting
24 hour (24P) blood samples were also obtained. Blood samples were analyzed for glutamine, potassium, sodium,
aldosterone, arginine vasopressin (AVP), C-reactive protein (CRP), interleukin-6 (IL-6), malondialdehyde (MDA),
testosterone, cortisol, ACTH, growth hormone and creatine kinase. Statistical evaluation of performance, hormonal
and biochemical changes was accomplished using a repeated measures analysis of variance.
Results: Glutamine concentrations for T5 were significantly higher at RHY and IP than T2 - T4. When examining
performance changes (difference between T2 - T5 and T1), significantly greater times to exhaustion occurred
during T4 (130.2 ± 340.2 sec) and T5 (157.4 ± 263.1 sec) compared to T2 (455.6 ± 245.0 sec). Plasma sodium
concentrations were greater (p < 0.05) at RHY and IP for T2 than all other trials. Aldosterone concentrations at RHY
and IP were significantly lower than that at BL and DHY. AVP was significantly elevated at DHY, RHY and IP
compared to BL measures. No significant differences were observed between trials in CRP, IL-6, MDA, or in any of
the other hormonal or biochemical measures.
Conclusion: Results demonstrate that AG supplementation provided a significant ergogenic benefit by increasing
time to exhaustion during a mild hydration stress. This ergogenic effect was likely mediated by an enhanced fluid
and electrolyte uptake.
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Background
During dehydration fluid moves from the plasma to
both intracellular and extracellular spaces and then
eventually back to the circulation [1,2]. Pressure changes
involving hydrostatic, oncotic and osmotic forces control
the dynamics of fluid movement [1]. This has important
implications for thermoregulation and athletic perfor-
mance. Significant performance decrements have been
shown with hypohydration levels of only 2% [3]. Consid-
ering that a thirst sensation may not develop until this
level of hypohydration has already been reached, it
becomes critical for athletes to rehydrate before they
feel the need to drink.
Several sport drinks are marketed to be a more effec-
tive means of promoting rehydration and maintaining
exercise performance than water alone. However, little
research is available to support the efficacy of these
drinks during relatively short duration endurance exer-
cise (≤ 2 hr). Water appears as effective as any sports
drink during exercise in maintaining performance and
thermoregulation [4]. Interestingly, recent advances in
sport supplements suggest the use of certain organic
osmolytes such as glycine betaine may provide some
protection of intracellular fluid volume [5]; however, its
ability to affect performance is not clear.
Recent research demonstrates that certain amino acids
may also promote rehydration by enhancing water and
electrolyte absorption [6]. Glutamine has been reported
to increase electrolyte and water absorption in both ani-
mal and human subjects suffering from intestinal infec-
tions [7-9], but not in others [10]. However, differences
may be related to the stability issues related to gluta-
mine. Fürst [11] suggested that glutamine derivatives
such as alanyl-glutamine may be more stable than gluta-
mine by itself, especially at low pH. This could be a
potential scenario during exercise when increases in lac-
tic acid are common. Lima and colleagues [6] reported
that alanine and glutamine together is more stable than
glutamine alone in increasing electrolyte and water
absorption, likely via an improvement in ion transpor-
ters within intestinal epithelia.
Both glutamine and alanine/glutamine in combination
have been shown to be effective for antioxidant defense
during situations of severe illness [12-14]. In addition,
glutamine has been shown to be an effective modulator
of the immune response to exercise [15] and possibly
improve athletic performance [16]. However, there is
considerable debate in this area [17], which justifies
further investigation. Thus, the purpose of this study
was to examine the efficacy of two different doses (0.2
g·kg-1 and 0.05 g·kg-1) of the dipeptide L-Alanyl-L-Glu-
tamine on performance, recovery and the fluid regula-
tory response during an exhaustive endurance exercise
protocol following a 2.5% dehydration stress. In addi-
tion, the effect of this dipeptide L-Alanyl-L-Glutamine
on endocrine and biochemical markers of inflammation,
oxidative stress and immune response during the exer-
cise and dehydration stress was also examined.
Methods
Subjects
Ten college-aged males (20.8 ± 0.6 y; 176.8 ± 7.2 cm;
77.4 ± 10.5 kg; 12.3 ± 4.6% body fat) volunteered for
this study. Prior to participation, each subject was
informed of all procedures, risks and benefits and com-
pleted written informed consent approved by the Insti-
tutional Review Board. Subjects ceased use of additional
nutritional supplements for at least four weeks prior to
the study. Screening for supplement use was accom-
plished via a health history questionnaire completed
during the subject recruitment phase.
Protocol
Prior to the onset of the study subjects reported to the
Human Performance Laboratory (HPL) for determina-
tion of baseline body mass. These measures occurred on
nonconsecutive days approximately one week before the
start of experimental testing. Subjects were weighed dur-
ing these visits in a postabsorptive, euhydrated state to
establish a baseline body weight. Upon arrival, subjects
voided their bladder for urinary measures of osmolality
(Uosm) by freezing point depression (Model 3320;
Micro-Sample Osmometer, Advanced Instruments, Inc.,
Norwood, MA) and urine specific gravity (Usg) by
refractometry (A300CL-E01, Atago, Tokyo, Japan) to
document euhydration on all preliminary days; Usg ≤
1.020 was defined as euhydration [18]. During the first
session (T1) subjects performed a graded maximal aero-
bic capacity test ( VO  2 max ) on an electromagnetically
braked cycle ergometer (Ergo 800, SensorMedics, Inc.,
Yorba Linda, CA). The VO  2 max test was administered
to establish workloads for the subsequent endurance
tests. Oxygen consumption ( VO2 ), respiratory exchange
ratio (RER), and minute ventilation ( VE ) were measured
(ULTIMA, MedGraphics Corporation, St. Paul, MN).
Gas analyzers were calibrated using gases provided by
MedGraphics Corporation: 1) calibration gas: 5% CO2,
12% O2, balance N2; and 2) reference gas: 21% O2, bal-
ance N2. Gas calibration was conducted before each
trial. Heart rate (HR) was measured via telemetry
(Pacer, Polar CIC, Inc., Port Washington, NY).
On four subsequent visits (T2-T5) to the HPL, sub-
jects dehydrated by 2.5% of baseline body mass. On the
occasion that a dehydration protocol was not employed
the subjects reported to the HPL in a euhydrated
state to provide a baseline blood draw and perform the
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exercise protocol. This trial (T1) provided baseline per-
formance data in optimal conditions without a hydration
stress. All performance comparisons were made to this
trial. In one trial (T2) subjects achieved their goal
weight and rested in a recumbent position for 45 min-
utes before commencing the exercise session. In the
subsequent three trials subjects reached their goal
weight and then rehydrated to -1.5% of their baseline
body mass by drinking either water (T3) or two different
doses (T4 and T5) of the alanine-glutamine (AG) sup-
plement (0.05 g·kg-1 and 0.2 g·kg-1, respectively). During
the hydration trials (T3 - T5), the exercise protocol
began 45 minutes following rehydration. The order of
the trials was randomized
Dehydration Protocol
On the night before testing (1700 hrs) subjects reported
to the HPL for weight and Usg measures to verify euhy-
dration. Subjects were instructed to not consume any
food or water until the next day when they reported
back to the HPL (0700 hrs). This resulted in an average
body mass change of -1.03 ± 1.3%. On the morning of
trials T2 - T5 subjects reported to the HPL were
weighed and then began the active dehydration protocol
to achieve the desired weight loss. The active dehydra-
tion protocol consisted of walking on a motorized tread-
mill at 3.4 mi·h-1 at a 2% incline. Subjects were fully
clothed in a training suit (long cotton heavy weight
fleece sweat pants and top). Nude body weight, HR, and
rating of perceived exertion were monitored at 20-min-
ute increments. The subjects continued to walk until
they (a) lost 2.5% of their body mass, (b) met preset
safety criteria, (c) displayed signs or symptoms of an
exercise-induced heat illness, or (d) reached volitional
fatigue. Dehydration was verified via Usg, Uosm and
plasma osmolality (Posm). Total exercise time to achieve
hypohydration (-2.5% weight loss) was 62.5 ± 44.2 min.
There were no significant differences in time to reach
goal body mass among trials.
Supplement Schedule
Subjects rehydrated to -1.5% body mass by consuming
the supplement or the placebo (water) following the
dehydration protocol. The L-alanyl-L-glutamine supple-
ment (0.2 g·kg-1 or 0.05 g·kg-1 body mass per liter) mar-
keted as “Sustamine™” (Kyowa Hakko USA, New York,
NY) was mixed with water and was indistinguishable in
appearance and taste from the placebo.
Time to Exhaustion Test
After the dehydration and rehydration phase, subjects
began the exercise protocol. Subjects exercised at a
workload that elicited 75% of their VO  2 max on a cycle
ergometer. Subjects were encouraged to give their best
effort during each trial, and were verbally encouraged
throughout each exercise trial. VO2 , RER, VE , RER,
and HR, were measured continuously. HR and blood
pressure (BP) were recorded before and at the conclu-
sion of exercise. Time to exhaustion was determined as
the time that the subject could no longer maintain the
workload and/or reached volitional exhaustion.
Blood Measures
A baseline (BL) blood draw occurred during T1. No
other blood was drawn during that trial. The BL blood
sample was drawn following a 15-min equilibration per-
iod prior to exercise. All day of trial blood samples
(DHY, RHY and IP) were obtained using a 20-gauge
Teflon cannula placed in a superficial forearm vein
using a 3-way stopcock with a male luer lock adapter.
The cannula was maintained patent using an isotonic
saline solution (with 10% heparin). During trials T2 - T5
blood draws occurred once goal body mass was achieved
(DHY), immediately prior to the exercise stress (RHY)
and immediately following the exercise protocol (IP). IP
blood samples were taken within 15 seconds of exercise
cessation. Subjects returned to the laboratory 24-h post-
exercise for an additional blood draw (24P). All BL and
24P blood samples were drawn with a plastic syringe
while the subject was in a seated position. These blood
samples were obtained from an antecubital arm vein
using a 20-gauge disposable needle equipped with a
Vacutainer® tube holder (Becton Dickinson, Franklin
Lakes, NJ) with the subject in a seated position. Each
subjects’ blood samples were obtained at the same time
of day during each session. Blood samples were drawn
into plain or EDTA treated tubes (Vacutainer, Becton
Dickinson, Franklin Lakes, NJ). Blood samples were ana-
lyzed in triplicate for hematocrit via microcapillary tech-
nique and hemoglobin via the cyanmethemoglobin
method (Sigma Diagnostics, St. Louis, MO). The
remaining whole blood was centrifuged for 15 min at
1500 g at 4°C. Resulting plasma and serum were ali-
quoted and stored at -80°C until analysis. Samples were
thawed only once.
Biochemical and Hormonal Analyses
Serum testosterone (TEST), cortisol (CORT) and growth
hormone (GH) concentrations were determined using
enzyme immunoassays (EIA) and enzyme-linked immu-
nosorbent assays (ELISA) (Diagnostic Systems Labora-
tory, Webster, TX). Serum aldosterone (ALD) and IL-6
concentrations were determined using an EIA assay
(ALPCO Diagnostics, Salem, NH). Plasma arginine vaso-
pressin (AVP) concentrations were determined using an
EIA assay (Cayman Chemical Co, Ann Arbor, MI).
Plasma adrenocorticotrophic hormone (ACTH, ALPCO
Diagnostics, Salem, NH), C-reactive protein (CRP,
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Diagnostic Systems Laboratory, Webster, TX), and mal-
ondialdehyde (MDA, Cell Biolabs Inc., San Diego, CA)
concentrations were assayed in duplicate via ELISA.
Determination of serum immunoreactivity values was
made using a SpectraMax340 Spectrophotometer (Mole-
cular Devices, Sunnyvale, CA). Serum creatine kinase
(CK) concentrations were determined at 340 nm on a
spectrophotometer (Pointe Scientific, Inc, Canton, MI).
Plasma glutamine, glucose and lactate (La-) concentra-
tions were determined in duplicate with an automated
analyzer (Analox GM7 enzymatic metabolite analyzer,
Analox Instruments USA, Lunenburg, MA). Plasma
sodium and potassium concentrations were assessed via
ion-selective electrodes (EasyElectrolyte, Medica, Bed-
ford, MA). To eliminate inter-assay variance, all samples
were analyzed in the same assay run. Intra-assay var-
iance for all assays was < 10%. Plasma volume shifts fol-
lowing the workout were calculated using the formula
of Dill & Costill [19].
Statistical Analysis
All data were assessed and met assumptions for normal
distribution, homogeneity of variance, and sample inde-
pendence. Statistical evaluation of performance, hormo-
nal and biochemical changes were analyzed using a
repeated measures analysis of variance (ANOVA). In the
event of a significant F- ratio, LSD post-hoc tests were
used for pairwise comparisons. Prior to the ANOVA,
Plasma volume shifts, performance comparisons, and
area under the curve (AUC) calculated using standard
trapezoidal technique were analyzed using a One-Way
ANOVA. Significance was accepted at an alpha level of
p ≤ 0.05. All data are reported as mean ± SD.
Results
Usg (1.026 ± 0.004), Uosm (813 ± 299 mOsm) and Posm
(297.0 ± 4.6 mOsm) were similar for all trials at DHY.
These results reflected the overnight fasting and exer-
cise-induced dehydration performed during prior to
each trial. Plasma glutamine concentrations were signifi-
cantly higher for all groups at RHY and IP compared to
BL (p = 0.002 and p = 0.000, respectively) and DHY (p
= 0.001 and p = 0.000, respectively) (Figure 1). [Gluta-
mine] for T5 were significantly higher at RHY and IP
than T2 - T4. AUC analysis showed significantly greater
[glutamine] for T5 at all time points compared to the
other experimental trials (see Figure 2).
Time to exhaustion was significantly reduced during
T2 than at any other experimental trial (see Figure 3).
When examining Δ performance (difference between
each experimental trial and T1), time to exhaustion was
significantly greater during T4 (130.2 ± 340.2 sec) and
T5 (157.4 ± 263.1 sec) compared to T2 (455.6 ± 245.0
sec, p = 0.05 and p = 0.01, respectively) (Figure 4). No
Figure 1 Plasma Glutamine Concentrations. There was a
significant main effect for trial between T2 and T5. # =
significant main effect for time versus BL and DHY; a = significantly
different from T2, T3, and T4.
Figure 2 AUC Glutamine. * = Significantly different from T2
Figure 3 Time to Exhaustion. * Significantly different from all
other trials.
Hoffman et al. Journal of the International Society of Sports Nutrition 2010, 7:8
http://www.jissn.com/content/7/1/8
Page 4 of 12
other between trial differences were noted. Cardiovascu-
lar changes during exercise are depicted in Table 1. No
significant differences in either resting or post-exercise
HR occurred between trials. In addition, no differences
occurred in resting BP between trials, however, systolic
BP post-exercise was significantly lower at T2 and T3
compared to T1. No other differences existed in systolic
or diastolic BP response between trials. No changes in
RER occurred between trials.
There were significant main effects for both La- (p =
0.000) and GLU (p = 0.000) responses to the exercise
protocol (Table 2). There were also significant elevations
at IP in both of these variables compared to all other
time points. However, there were no significant differ-
ences between trials. A main effect for time (p = 0.011)
also occurred for plasma osmolality. Posm at IP (300.4 ±
16.7 mOsm) was significantly elevated compared to BL
(295.0 ± 3.9 mOsm, p = 0.010) and RHY (293.9 ± 4.9
mOsm, p = 0.002) but, not DHY (297.0 ± 4.5 mOsm, p
= 0.100). No other significant differences were noted. In
addition, no between trial differences in Posm were
observed. A significant main effect for time (p = 0.001)
was also observed for plasma potassium concentrations.
Plasma potassium was significantly elevated at IP com-
pared to BL (p = 000), DHY (p = 0.000) and RHY (p =
0.017). No other differences were noted and no between
trial effects were observed. A significant main effect for
time (p = 0.000) was also observed for plasma sodium.
Plasma sodium concentrations at IP and DHY were sig-
nificantly greater than that observed at BL (p = 0.000
and p = 0.000, respectively) and RHY (p = 0.000 and p
= 0.000, respectively). When collapsed across time,
plasma sodium concentrations were significantly greater
at T2 than compared to all other experimental condi-
tions. Plasma sodium concentrations were also signifi-
cantly greater for T2 than all other experimental trials
at RHY (p = 0.000) and IP (p = 0.000). AUC analysis
also demonstrated a significantly greater sodium con-
centration for T2 compared to all other trials.
The ALD response to the experimental trials is pre-
sented in Figure 5. A significant main effect for time (p
= 0.013) was observed. [ALD] at RHY and IP were sig-
nificantly lower than that at BL and DHY (Figure 5). No
other significant differences were noted and no signifi-
cant interactions were observed. The plasma AVP
responses are shown in Figure 6. A significant main
effect for time (p = 0.000) was also observed. AVP was
significantly elevated at DHY (p = 0.000), RHY (p =
0.000) and IP (p = 0.000) compared to BL measures. In
addition, AVP concentrations at DHY were significantly
higher (p = 0.05) than IP across all trials. There were no
significant differences between trials, and no significant
interactions between time and trial.
No significant differences were observed between trials
in CRP, IL-6, and MDA response to the exercise and
hydration stress (see Figures 7, 8 and 9, respectively). A
significant main effect for time was observed for both
CRP (p = 0.000) and MDA (p = 0.000). BL concentra-
tions for both of these variables were significantly lower
than all other time points. There was a significant main
effect for trial for MDA between T3 and T5 versus T2
(p = 0.004 and p = 0.008, respectively) and T4 (p = 0.05
and p = 0.011, respectively). Evaluation of the response
of IL-6 revealed a significant main effect for time (p =
Figure 4 Δ Time to Exhaustion. * = Significantly different from ΔT2
Table 1 Cardiovascular Changes during Exercise Protocol
Variable T1 T2 T3 T4 T5
Resting Heart Rate (beats·min-1) 75.7 ± 14.6 78.6 ± 15.4 72.9 ± 13.8 76.7 ± 17.6 76.9 ± 15.8
IP Heart Rate (beats·min-1) 180.2 ± 13.8 187.8 ± 9.6 179.7 ± 18.0 183.0 ± 12.5 184.2 ± 13.0
Resting SBP (mmHg) 117.0 ± 6.0 112.4 ± 4.8 111.5 ± 5.5 114.8 ± 5.2 113.0 ± 7.7
IP SBP (mmHg) 167.3 ± 6.0 131.3 ± 8.1* 136.4 ± 20.3* 150.3 ± 23.0 152.5 ± 19.6
Resting DBP (mmHg) 77.3 ± 3.6 74.7 ± 4.8 75.4 ± 3.8 79.0 ± 2.7 77.2 ± 5.9
IP DBP (mmHg) 88.4 ± 7.0 86.0 ± 3.5 84.0 ± 9.4 88.3 ± 11.6 84.8 ± 11.9
RER 1.12 ± 0.09 1.10 ± 0.07 1.12 ± 0.07 1.08 ± 0.10 1.07 ± 0.08
IP = immediate post; SBP = systolic blood pressure; DBP = diastolic blood pressure. * = significant difference versus T1. All data are reported as mean ± SD.
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0.000). IL-6 concentrations were significantly greater at
IP than at BL (p = 0.000), DHY (p = 0.000), and IP (p =
0.000). In addition, IL-6 concentrations at RHY were
significantly higher than at BL (p = 0.000) and 24P (p =
0.006). AUC analysis for CRP, IL-6 and MDA did not
reveal any significant differences between trials.
No significant differences from BL were seen in the tes-
tosterone response to the exercise and dehydration stress
during any experimental trial (Figure 10). A significant
main effect for time was seen in both the ACTH (p =
0.000) and cortisol (p = 0.000) response to the exercise
and dehydration protocol (Figure 11 and 12, respectively).
When collapsed across trials, significant elevations in cor-
tisol and ACTH concentrations were seen at IP and 24P
compared to BL, DHY and RHY. No other significant dif-
ferences were noted and no between trial effects were
observed. A significant main effect for time (p = 0.000)
was seen in the growth hormone response. When col-
lapsed across trials, growth hormone concentrations were
significantly elevated at IP compared to all other time
Table 2 Plasma Lactate, Glucose, Osmolality and Electrolyte Response to Exercise
Variable T2 T3 T4 T5
Time Point
Lactate (mmol·L-1) DHY 1.9 ± 0.6 1.9 ± 0.6 2.0 ± 0.6 1.7 ± 0.6
RHY 1.8 ± 0.5 2.1 ± 0.4 2.0 ± 0.5 2.1 ± 0.4
IP* 11.1 ± 2.3 11.9 ± 2.2 9.9 ± 4.2 11.7 ± 2.2
Glucose (mmol·L-1) BL 5.8 ± 1.2 5.8 ± 1.2 5.8 ± 1.2 5.8 ± 1.2
DHY 6.5 ± 1.8 6.4 ± 1.1 6.4 ± 1.4 5.7 ± 1.2
RHY 5.9 ± 1.7 6.2 ± 1.1 6.4 ± 0.9 5.6 ± 1.2
IP* 6.9 ± 1.6 8.6 ± 1.5 8.4 ± 1.9 7.4 ± 2.6
Osmolality (mOsm) BL 295 ± 4 295 ± 4 295 ± 4 295 ± 4
DHY 298 ± 5 298 ± 5 296 ± 4 298 ± 6
RHY 298 ± 6 293 ± 5 292 ± 4 294 ± 4
IP# 308 ± 5 299 ± 4 302 ± 5 303 ± 7
Potassium (mmol·L-1) BL 4.1 ± 0.4 4.1 ± 0.4 4.1 ± 0.4 4.1 ± 0.4
DHY 4.2 ± 0.9 4.0 ± 0.3 4.1 ± 0.3 4.0 ± 0.3
RHY 4.1 ± 0.2 4.3 ± 0.3 4.3 ± 0.6 4.1 ± 0.4
IP* 4.5 ± 0.7 4.5 ± 0.5 4.4 ± 0.4 4.5 ± 0.6
Sodium (mmol·L-1) BL 139.4 ± 1.1 139.4 ± 1.1 139.4 ± 1.1 139.4 ± 1.1
DHY* 141.7 ± 1.1 141.3 ± 1.6 141.1 ± 2.5 141.2 ± 1.4
RHY 141.5 ± 1.5@ 139.6 ± 1.9 138.7 ± 1.9 138.7 ± 1.6
IP# 144.0 ± 2.2@ 140.6 ± 1.8 140.7 ± 2.0 140.2 ± 1.3
* = Significant main effect compared to all other time points. # = Significant main effect compared to BL and RHY. @ = significantly different than T3 - T5. BL =
baseline; DHY = dehydration; RHY = rehydration; IP = immediate post-exercise.
Figure 5 Serum Aldosterone Response. # = significant main
effect for time between BL and DHY. Figure 6 Arginine Vasopressin. # = significant main effect for
time BL versus DHY, RHY and IP. * = Significant main effect
between DHY and IP.
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Figure 7 C-Reactive Protein Response. * = significant main effect
for time BL.
Figure 8 IL-6 Response. # = significant main effect for time versus
BL, DHY and 24P; * significant main effect for time versus BL and
24P.
Figure 9 MDA Response. # = significant main effect for time
versus DHY, RHY, IP, and 24P; There was a significant main effect for
Trial between T3 and T5 versus T2 and T4.
Figure 10 Testosterone Response.
Figure 11 ACTH Response. # = significant main effect for time
versus BL, DHY and RHY
Figure 12 Cortisol Response. # = significant main effect for time
versus BL, DHY and RHY
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points (Figure 13). No other differences were observed.
AUC analyses for testosterone, ACTH, cortisol and
growth hormone did not result in any significant differ-
ences between trials. No significant difference from base-
line concentrations (43.9 ± 18.7 IU) was seen in creatine
kinase concentrations during any trial.
Plasma volumes decreased -5.45 ± 11.38% at DHY for
all experimental trials, plasma volumes were decreased
at RHY (-6.78 ± 11.27%) for all experimental trials and
continued to decrease at IP (-21.44 ± 10.54%). However,
the differences between trials were not significant. Blood
variables were not corrected for plasma volume shifts
due to the importance of molar exposure at the tissue
receptor level.
Discussion
The results of this study showed that when subjects are
hypohydrated by 2.5% of their body mass and exercise
to exhaustion, significant performance decrements
occurred. However, when subjects ingested the AG sup-
plement during the rehydration period (T4 and T5) the
magnitude of performance decrement was significantly
less compared to the dehydrated condition (T2). Water
alone (T3) did not appear to significantly reduce the
performance decrement. Despite significant performance
improvements for both T4 and T5, glutamine concen-
trations were significantly elevated at only T5 for both
RHY and IP compared to all other trials. As expected,
the higher dose of AG produced a greater increase in
plasma glutamine concentrations. The time course of
glutamine appearance in plasma is similar to that
reported by Klassen and colleagues [20]. In that study, a
20 g oral feeding (approximate to the high dose [T5]
used in this study) resulted in a peak increase occurring
at 49 ± 8 min (range 30 - 120 min) following dosing,
which corresponded to the RHY and IP blood draws.
Although dosing patterns of 0.1 g·kg·BM-1 can increase
plasma glutamine concentration by approximately 50%
[21], the ability to increase plasma glutamine concentra-
tions with doses lower than 0.1 g·kg·BM-1 is not clear.
Based on the present findings a dose of 0.05 g·kg·BM-1
AG did not result in a significant elevation in plasma
glutamine concentrations.
Despite the lack of any significant increase in plasma
glutamine concentrations at T4, significant performance
improvements were found for both T4 and T5. It is pos-
sible that in instances where plasma glutamine concen-
trations are normal, small bolus samples may be
sufficient to offset mild hydration perturbations. The AG
dipeptide has an important role in fluid and electrolyte
uptake in the gut. AG appears to increase electrolyte and
fluid uptake across the intestines by increasing ion trans-
port through an enhanced signaling pathway within the
intestinal mucosal cells [6,22]. Further, AG supplementa-
tion has also been demonstrated to enhance muscle glu-
tamine uptake [23]. Although speculative, it is likely that
an enhanced glutamine uptake by skeletal muscle will
also result in a greater sodium uptake, which is supported
by the reduced sodium concentrations at T4 - T5 com-
pared to T2. The enhanced sodium uptake by skeletal
muscle may have contributed to a reduction in fatigue by
maintaining strength and efficiency of muscle contracti-
lity [24]. In addition, although plasma glucose concentra-
tions were not different between trials, alanine is a
gluconeogenic substrate and may have contributed to the
delay in fatigue by sparing muscle glycogen [25,26].
ALD responses were significantly lower at RHY and IP
for all trials, with no between trials differences observed.
Although ALD is reported to respond in a graded man-
ner to levels of hypohydration [27,28], the magnitude of
hypohydration in this study was likely not sufficient to
stimulate increased ALD production, and rehydration
likely resulted in the significant decline of ALD across
trials at RHY and IP. These findings agree with observa-
tions that ALD concentrations will decline when water
or electrolyte drinks are provided during exercise [29].
The similarity in the ALD response found in this study
may also be attributed to similar plasma volume changes
observed between trials [29]. In addition, ALD is also
stimulated by changes in BP [30]. In this present study,
there was a significantly lower BP at IP during the T2
and T3 trials compared to T1. This most likely reflected
a greater local fatigue resulting from the hydration per-
turbation contributing to the reduced time to exhaus-
tion compared to T4 and T5 (an approximate 20 mmHg
difference [p > 0.05] was found between post-exercise
systolic BP at T2, T3 compared to T4 and T5). The sig-
nificantly lower ALD responses at RHY and IP for all
trials likely reflect the lack of a strong single stimulus (e.
g. level of hypohydration) and represent the multitude of
physiological factors that influence ALD secretion.
Figure 13 Growth Hormone Response. # = significant main effect
for time versus BL, DHY RHY, and 24P
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Our findings also indicated that AVP was significantly
elevated from BL at all time points and that AVP concen-
trations at IP were significantly greater than DHY as well.
However, the AG supplement was unable to alter the
response of AVP to this mild dehydration and exercise
protocol. The response to the exercise protocol was con-
sistent with previous studies examining a similar exercise
intensity [28]. Changes in AVP concentrations are depen-
dent upon exercise intensity and changes in Posm and
blood volume [31,32]; thus it is not surprising to see no
significant differences between the trials in the AVP
response considering that no between trial differences
were noted in Posm or plasma volume changes. The mild
dehydration and exercise protocol was unable to create
any difference to the fluid regulatory response between
the various trials. Previous studies examining the effect of
hypohydration levels have typically examined body water
deficits of greater magnitudes (~5%) and greater differen-
tials than that used in this present study [28,29].
CRP is often used as a marker of inflammation and
muscle damage [33-35]. Previous studies have shown
that CRP will increase in response to prolonged physical
activity such as triathlons [35] and marathons [33] but
not during shorter duration exercise [34,36]. It is likely
that the relatively short duration in time to exhaustion,
despite the added mild dehydration stress did not cause
a significant inflammatory response. Many studies use
CK as a marker for muscle damage and have suggested
that a rapid acute phase inflammatory response
(reflected by an increase in CRP within 24 hours post-
exercise during eccentric exercise in untrained indivi-
duals) can initiate delayed onset of muscle soreness and
additional tissue necrosis occurring following 24 hours
post-exercise is reflected by elevations in CK [37].
Although CRP concentrations observed in this study
were significantly elevated from baseline levels, they
were not different between DHY, RHY, IP and 24P sug-
gesting that any changes may have been the result of
plasma volume shifts and not due to an inflammatory
response. This is supported by the response of CK dur-
ing each trial (no change from baseline concentrations).
Interestingly, the AG supplement was unable to provide
any indication for an attenuation of the inflammatory or
muscle damage response to the exercise protocol. This
is likely due to the limited inflammatory response and
lack of a clear indicator of muscle damage as measured
by CK.
There was a significant elevation in serum concentra-
tions of IL-6 at IP compared to BL, DHY and 24P and
at RHY compared to BL and 24P. This response is con-
sistent with previous studies that have shown significant
elevations following prolonged endurance [33,35,38] and
eccentric exercise [34]. IL-6 is produced in active skele-
tal tissue [39] and in the central nervous system [40].
Exercise is a potent stimulator of IL-6 production, with
elevations greater than 100-fold reported [41]. It is
thought that increases in IL-6 modulates CRP produc-
tion in the liver [42] and operate synergistically to
enhance the inflammatory response to exercise. The
potential outcome from this inflammatory response is
the risk for significant tissue damage and reduced recov-
ery capability.
Several investigations have examined the ability of
nutritional intervention to attenuate the post-exercise
inflammatory response [43,44]. Carbohydrate ingestion
[44] and a vitamin E and omega-3 fatty acid combina-
tion [43] have been successful in attenuating the IL-6
response to exercise. In contrast, glutamine supplemen-
tation has been shown to enhance plasma IL-6 produc-
tion [38], while an AG dipepide has shown to have no
effect on cytokine production in healthy individuals [45].
Hiscock and colleagues [38] suggested that the enhanced
glutamine uptake by skeletal muscle would increase or
maintain the production of IL-6. This hypothesis may
be more consistent with the anti-inflammatory role sug-
gested of IL-6 during exercise [46]. Increases in IL-6
concentrations have been consistently reported without
corresponding muscle damage [46], and is supported by
the results of this present study. The difference between
this study and the results of Hiscock et al., [38] may be
related to the length of exercise and the training experi-
ence of the subjects. In the present study the duration
of exercise ranged from 5 - 47 minutes following the
~60 minute active dehydration protocol, in recreation-
ally trained individuals, while the subjects in Hiscock’s
study were untrained and required to perform a 2-hr
time trial using the same exercise intensity as employed
in this study. However, those subjects were euhydrated
and allowed to drink ad libitum. It is unlikely that dos-
ing impacted these results, considering that the gluta-
mine dose used in Hiscock’s study (3.5 g) was similar to
the low dosing trial (T4).
[MDA] were significantly elevated from baseline for
all trials. This is not surprising considering that exer-
cise is a potent stimulator of the formation of reactive
oxygen species [47]. The results of this study are also
consistent with previous research demonstrating ele-
vated oxidative stress following a mild dehydration and
exercise to exhaustion protocol [48]. However, in con-
trast to Paik and colleagues [48] rehydration with
water, or water and the supplement, was unable to
reduce the MDA response to the exercise protocol. It
is likely that the differences between these two studies
may reflect the methods used to achieve dehydration.
Paik et al., [48] used passive means in the heat (sauna
exposure) to achieve 3% hypohydration, while this pre-
sent study used both a passive and active (exercise)
dehydration protocol to achieve the 2.5% body weight
Hoffman et al. Journal of the International Society of Sports Nutrition 2010, 7:8
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loss. Although speculative, it is possible that differences
between methods used for dehydration may have
resulted in a different oxidative stress. The time used
to achieve body weight loss, although performed at a
lower intensity of exercise, resulted in significant eleva-
tions in MDA concentrations that were not altered by
water or water and AG.
The anabolic and catabolic response to the study proto-
col did not differ among trials suggesting that the supple-
ment was unable to provide any significant benefit
regarding enhanced recovery from the exercise and hypo-
hydration stress. It is also possible that these hormonal
measures may not have been sensitive enough for asses-
sing recovery from a moderate dehydration and endurance
exercise protocol [49]. [TEST] did not significantly elevate
from baseline levels following exercise despite a reduction
in plasma volume. This is not surprising considering that
subjects experienced only a moderate hypohydration stress
and that time to exhaustion ranged from 13 - 18 minutes.
Exercise of relatively short duration (i.e. 10-20 minutes)
does not appear to increase [TEST] [50,51], even with a
mild hydration perturbation in fit individuals [52].
The CORT response was consistent with previous stu-
dies that have shown that hydration levels do not influ-
ence [CORT] [52,53]. The post-exercise elevation in
CORT was also consistent with the metabolic stress
associated with moderate exercise and hypohydration
[53,54]. Results of this study though were unable to
show that CORT responses can differentiate between
levels of hypohydration, which contrasts with observa-
tions made by Judelson et al., [55] and Maresh et al.,
[54]. However, the ability for hypohydration to modify
the catabolic response to exercise appears to be more
relevant when hypohydration reaches 5% or greater, or
when exercise is performed at higher exercise intensities
[54,55]. These findings also suggest that the pituitary-
adrenal axis responds similarly to this exercise and
hypohydration perturbation as ACTH responded in a
similar pattern as CORT, with no influence from the
AG supplementation.
GH secretion patterns have been shown to be quite
responsive to changes in the acid-base balance of mus-
cle [56]. Considering that no differences were noted in
the La- response between the trials, the GH response
to the exercise and hypohydration stress appears to
have responded in a normal manner. These results are
also in agreement with Judelson et al., [55] but, con-
trast with Peyreigne and colleagues [57]. In this latter
study, it was suggested that a hydration stress could
blunt the GH response to exercise. Interestingly, there
was an 18% and 20% greater GH response (p > 0.05)
during T3 and T4 versus T2, respectively, while a 42%
difference was found between T5 and T2 (p > 0.05).
Although these responses were not significantly
different, it does suggest an interesting trend that pro-
vided some support to previous results [57]. Whether
the high dose glutamine ingestion played a role in this
response is not clear. Previous investigations have sug-
gested that glutamine concentrations can elevate the
GH response at rest [58,59], but not exercise [58]. It
appears that the most compelling stimulus for gluta-
mine’s role in stimulating GH release is during pro-
longed critical illness when plasma glutamine
concentrations are below normal levels [60]. Thus, the
high variability in the GH response in this study may
be attributed to the normal glutamine concentrations
at rest, however the largest gains in GH occurred dur-
ing the trial (T5) that glutamine concentrations were
significantly higher than T2 - T4.
In conclusion, the results of this study demonstrate that
AG supplementation provides significant ergogenic bene-
fits by increasing time to exhaustion during a mild hydra-
tion stress. This ergogenic effect was likely mediated by
an enhanced fluid and electrolyte uptake. AG supplemen-
tation, irrespective of dosing, did not have any effect on
immune, inflammatory or oxidative stress responses.
Results also indicated that the AG supplement did not
influence the pituitary-adrenal-testicular axis during this
exercise and mild hypohydration perturbation.
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